Humanwell Healthcare Group Co Ltd Asset Resilience Ratio

Latest as of June 2026: 2.44%

Humanwell Healthcare Group Co Ltd asset resilience ratio. Humanwell Healthcare Group Co Ltd (600079) has an Asset Resilience Ratio of 2.44% as of June 2026. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See Humanwell Healthcare Group Co Ltd (600079) defensive interval to measure how many days the company can operate on defensive assets alone.

Liquid Assets

CN¥908.24 Million

≈ $132.90 Million USD Cash + Short-term Investments

Total Assets

CN¥37.19 Billion

≈ $5.44 Billion USD All company assets

Resilience Assessment

Low

Financial Resilience Level

Asset Resilience Ratio of Humanwell Healthcare Group Co Ltd (1994–2025)

Asset resilience ratio of Humanwell Healthcare Group Co Ltd from 1994 to 2025. This chart shows how Humanwell Healthcare Group Co Ltd's Asset Resilience Ratio has changed over time. Read Humanwell Healthcare Group Co Ltd total liabilities for a breakdown of total debt and financial obligations.

Liquid Assets Composition Over Time

This chart breaks down Humanwell Healthcare Group Co Ltd's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For the complete balance sheet picture, see Humanwell Healthcare Group Co Ltd (600079) total assets.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	CN¥0.00	0%
Short-term Investments	CN¥908.24 Million	2.44%
Total Liquid Assets	CN¥908.24 Million	2.44%

Asset Resilience Insights

Limited Liquidity: Humanwell Healthcare Group Co Ltd maintains only 2.44% of assets in liquid form.
This low level may indicate efficient asset utilization but could pose risks during economic downturns.
The company has significant short-term investments, indicating active treasury management.

Humanwell Healthcare Group Co Ltd Industry Peers by Asset Resilience Ratio

Compare Humanwell Healthcare Group Co Ltd's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
Takeda Pharmaceutical Company Limited F:TKDA	Drug Manufacturers - Specialty & Generic	0.69%
Takeda Pharmaceutical Co Ltd ADR NYSE:TAK	Drug Manufacturers - Specialty & Generic	4.94%
Richter Gedeon Vegyészeti Gyár Nyilvánosan Muködo Rt F:RIG2	Drug Manufacturers - Specialty & Generic	0.20%
Ajanta Pharma Limited NSE:AJANTPHARM	Drug Manufacturers - Specialty & Generic	14.99%
Changchun High & New Technology Industries Group Inc SHE:000661	Drug Manufacturers - Specialty & Generic	5.50%
Jiangsu Nhwa Pharmaceutical Co Ltd SHE:002262	Drug Manufacturers - Specialty & Generic	26.45%
Porton Fine Chemicals Ltd SHE:300363	Drug Manufacturers - Specialty & Generic	6.85%
Jubilant Pharmova Limited NSE:JUBLPHARMA	Drug Manufacturers - Specialty & Generic	1.26%

Humanwell Healthcare Group Co Ltd Asset Resilience Ratio by Year (1994–2025)

Humanwell Healthcare Group Co Ltd asset resilience ratio by year from 1994 to 2025. The table below shows the annual Asset Resilience Ratio data for Humanwell Healthcare Group Co Ltd.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2025-12-31	2.66%	CN¥976.01 Million ≈ $142.82 Million	CN¥36.75 Billion ≈ $5.38 Billion	-0.18pp
2024-12-31	2.83%	CN¥1.03 Billion ≈ $151.39 Million	CN¥36.51 Billion ≈ $5.34 Billion	+0.25pp
2023-12-31	2.59%	CN¥935.93 Million ≈ $136.96 Million	CN¥36.20 Billion ≈ $5.30 Billion	-0.04pp
2022-12-31	2.63%	CN¥945.72 Million ≈ $138.39 Million	CN¥36.02 Billion ≈ $5.27 Billion	-0.01pp
2021-12-31	2.64%	CN¥934.39 Million ≈ $136.73 Million	CN¥35.41 Billion ≈ $5.18 Billion	+0.26pp
2020-12-31	2.38%	CN¥771.47 Million ≈ $112.89 Million	CN¥32.42 Billion ≈ $4.74 Billion	+0.30pp
2019-12-31	2.08%	CN¥749.41 Million ≈ $109.66 Million	CN¥36.05 Billion ≈ $5.28 Billion	+2.03pp
2005-12-31	0.05%	CN¥1.00 Million ≈ $146.33K	CN¥2.04 Billion ≈ $299.24 Million	+0.04pp
2004-12-31	0.01%	CN¥95.05K ≈ $13.91K	CN¥1.82 Billion ≈ $267.02 Million	-0.05pp
2003-12-31	0.05%	CN¥897.24K ≈ $131.29K	CN¥1.69 Billion ≈ $246.75 Million	-0.38pp
2002-12-31	0.43%	CN¥6.17 Million ≈ $902.67K	CN¥1.43 Billion ≈ $208.81 Million	+0.43pp
2001-12-31	0.00%	CN¥6.80K ≈ $995.05	CN¥991.27 Million ≈ $145.05 Million	-0.02pp
2000-12-31	0.02%	CN¥116.19K ≈ $17.00K	CN¥518.12 Million ≈ $75.82 Million	-0.31pp
1995-12-31	0.33%	CN¥358.00K ≈ $52.39K	CN¥108.85 Million ≈ $15.93 Million	-0.31pp
1994-12-31	0.64%	CN¥625.00K ≈ $91.46K	CN¥97.44 Million ≈ $14.26 Million	--

pp = percentage points

About Humanwell Healthcare Group Co Ltd

SHG:600079 China Drug Manufacturers - Specialty & Generic

Market Cap

$4.66 Billion

CN¥31.84 Billion CNY

Market Cap Rank

#3623 Global

#469 in China

Share Price

CN¥19.51

Change (1 day)

+0.15%

52-Week Range

CN¥16.37 - CN¥20.82

All Time High

CN¥37.30